Where does Apterna Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Apterna Limited ranks #38,840 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Apterna Limited hold?

Apterna Limited holds 6 US utility patents granted between 2020 and 2023, spanning 5 technology areas.

What is Apterna Limited's Innovation Score?

Apterna Limited has an Innovation Score of 39.3 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Apterna Limited's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Apterna Limited.

What does claim depth mean for Apterna Limited's patents?

Apterna Limited's patents average 18.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Apterna Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Apterna Limited

Q: What technology areas does Apterna Limited focus on?

Apterna Limited's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 6 patents, ranking #1,557 of 4,144 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2020–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Apterna ranks #38,840 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.

#38,840
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.3/100): 18.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R38840 · Foreign Corporation #38,840 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #38,840/49,997
PHOTO-FINISH Applikate
CPC-NARROW C12N · 5 areas
INNOV-THIN 39.3/100
CLAIMS-RICH 18.8 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2023 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Applikate Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Apterna’s 39.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (17%) Velocity 13.3 pts (34%) Breadth 7.9 pts (20%) Claim depth 11.3 pts (29%)

Qualcomm Incorporated · highest

85
Apterna · this assignee

39
3D Lighting… · lowest

7

What this shows Apterna's Innovation Score is 39.3/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Apterna?

Each dot is one of Apterna’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Apterna’s own 18.8 claims/patent is ABOVE the 15.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Apterna vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Apterna's grants concentrate

Apterna Limited is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2020. By volume, Apterna sits between Applikate Technologies, Inc. and Aquasolution Corporation.

Apterna's three-year grant acceleration

Apterna Limited shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Applikate

6
Aprinoia Therapeu…

6
APT Advanced Poly…

6
Aptamir Therapeut…

6
Aptose Biosciences

6
Aqua Storage Reta…

6
Aquaoptics

6
Aquasolution

6
Apterna ◀

6

What this shows Apterna holds 6 patents at rank #38,668, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Apterna

By rank, the assignees closest to #38,668 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Apterna's primary technology class.

Apterna's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Apterna Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	16.7%
2021	1	16.7%
2022	3	50.0%
2023	1	16.7%

Which technologies does Apterna Limited patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

C07K - Peptides 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Apterna Limited's patent record in context - here's where to go next.

Apterna Limited's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #38,840 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Apterna Limited against Applikate Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.